MetLife Investment Management’s Strata Critical Medical Inc SRTA Stock Holding History

MetLife Investment Management’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$107K	Sell	25,493 -11,930	-32%	-$57.4K	﹤0.01%	2509
2025 Q4	$180K	Buy	37,423 +11,951	+47%	+$57.8K	﹤0.01%	2326
2025 Q3	$129K	Buy	+25,472	New	+$113K	﹤0.01%	2534
2025 Q2	–	Sell	-34,833	Closed	-$95.1K	–	2849
2025 Q1	$95.1K	Sell	34,833 -613	-2%	-$2.2K	﹤0.01%	2547
2024 Q4	$151K	Hold	35,446	–	–	﹤0.01%	2439
2024 Q3	$104K	Hold	35,446	–	–	﹤0.01%	2610
2024 Q2	$123K	Buy	35,446 +18,763	+112%	+$62.6K	﹤0.01%	2494
2024 Q1	$47.5K	Sell	16,683 -15,661	-48%	-$48.3K	﹤0.01%	2723
2023 Q4	$114K	Hold	32,344	–	–	﹤0.01%	2540
2023 Q3	$83.8K	Hold	32,344	–	–	﹤0.01%	2668
2023 Q2	$127K	Hold	32,344	–	–	﹤0.01%	2536
2023 Q1	$109K	Hold	32,344	–	–	﹤0.01%	2510
2022 Q4	$116K	Hold	32,344	–	–	﹤0.01%	2532
2022 Q3	$130K	Hold	32,344	–	–	﹤0.01%	2547
2022 Q2	$144K	Buy	+32,344	New	+$233K	﹤0.01%	2518

Other funds holding SRTA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PLC

Pillsbury Lake Capital San Francisco, California $221M AUM

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MetLife Investment Management's SRTA Position: Q1 2026 in Review

MetLife Investment Management reduced its Strata Critical Medical Inc (SRTA) stake by 32% in Q1 2026, selling an estimated $57.4K and leaving 25,493 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #2509.

MetLife Investment Management first reported a position in SRTA in Q2 2022 and has held it in 15 quarters since. The position peaked at $180K in Q4 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

MetLife Investment Management held 25,493 shares of Strata Critical Medical Inc worth $107K as of Q1 2026.
MetLife Investment Management sold 11,930 Strata Critical Medical Inc shares in Q1 2026, an estimated $57.4K.
Strata Critical Medical Inc made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2509 holding.
MetLife Investment Management first reported a position in Strata Critical Medical Inc in Q2 2022 and has held it in 15 quarters since.
MetLife Investment Management's Strata Critical Medical Inc position peaked at $180K in Q4 2025.
125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.